Novel Strategies in Artificial Organ Development: What Is the Future of Medicine?
Authors:
- Marta KlakMarta Klak
- Tomasz BryniarskiTBTomasz Bryniarski
- Patrycja KowalskaPKPatrycja Kowalska
- Magdalena GomolkaMGMagdalena Gomolka
- Grzegorz TymickiGTGrzegorz Tymicki
- Katarzyna KosowskaKKKatarzyna Kosowska
- Piotr CywoniukPCPiotr Cywoniuk
- Tomasz DobrzanskiTDTomasz Dobrzanski
- Pawel TurowskiPTPawel Turowski
- Michal WszolaMichal Wszola
Open Access
- 30 June 2020
- journal article
- review article
- Published by MDPI AG in Micromachines
- Vol. 11 (7) , 646
Abstract
The technology of tissue engineering is a rapidly evolving interdisciplinary field of science that elevates cell-based research from 2D cultures through organoids to whole bionic organs. 3D bioprinting and organ-on-a-chip approaches through generation of three-dimensional cultures at different scales, applied separately or combined, are widely used in basic studies, drug screening and regenerative medicine. They enable analyses of tissue-like conditions that yield much more reliable results than monolayer cell cultures. Annually, millions of animals worldwide are used for preclinical research. Therefore, the rapid assessment of drug efficacy and toxicity in the early stages of preclinical testing can significantly reduce the number of animals, bringing great ethical and financial benefits. In this review, we describe 3D bioprinting techniques and first examples of printed bionic organs. We also present the possibilities of microfluidic systems, based on the latest reports. We demonstrate the pros and cons of both technologies and indicate their use in the future of medicine.Keywords
Funding Information
- Narodowe Centrum Badań i Rozwoju (STRATEGMED3/305813/2/NCBR/2017)
This publication has 145 references indexed in Scilit:
- Tissue Engineered Skin Substitutes Created by Laser-Assisted Bioprinting Form Skin-Like Structures in the Dorsal Skin Fold Chamber in MicePLOS ONE, 2013
- Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffoldsBiofabrication, 2012
- Direct Human Cartilage Repair Using Three-Dimensional Bioprinting TechnologyTissue Engineering Part A, 2012
- Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chipLab on a Chip, 2011
- The extracellular matrix at a glanceJournal of Cell Science, 2010
- Multi-layered culture of human skin fibroblasts and keratinocytes through three-dimensional freeform fabricationBiomaterials, 2009
- Direct Cell Writing of 3D Microorgan for In Vitro Pharmacokinetic ModelTissue Engineering Part C: Methods, 2008
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Liver Cell Models in in Vitro ToxicologyEnvironmental Health Perspectives, 1998
- Primary Bioassay of Human Tumor Stem CellsScience, 1977